期刊文献+

性激素联合癌胚抗原对乳腺癌患者淋巴结转移的诊断价值分析 被引量:1

Analysis of the diagnostic value of sex hormone combined with carcinoembryonic antigen in lymph node metastasis of breast cancer patients
原文传递
导出
摘要 目的分析性激素联合癌胚抗原对乳腺癌患者淋巴结转移的诊断价值。方法收集2020年8月至2021年9月在山西医科大学第二医院行根治性手术切除的乳腺癌患者52例,经腋窝淋巴结超声检查后将其分为淋巴结未转移组与转移组。收集患者血液标本,获得血清并检测血清雌二醇、睾酮、孕酮及癌胚抗原水平,分析上述指标对患者淋巴结转移的诊断价值,借助Logistic风险回归模型分析手术切除后患者发生淋巴结转移的独立危险因素。结果未转移组患者与转移组患者肿瘤最大直径及是否绝经差异有统计学意义(均P<0.05),其余一般资料差异无统计学意义(均P>0.05)。未转移组患者血清雌二醇水平为(153.97±35.55)pg/ml、孕酮水平(0.33±0.05)ng/ml、癌胚抗原水平(11.44±3.77)ng/ml,转移组患者雌二醇水平为(207.19±52.11)pg/ml(t=4.13,P<0.001)、孕酮水平(0.38±0.04)ng/ml(t=4.01,P<0.001)、癌胚抗原水平(15.41±3.46)ng/ml(t=3.94,P<0.001),转移组患者以上3个指标显著升高。雌二醇曲线下面积为0.83,孕酮曲线下面积为0.80,癌胚抗原曲线下面积为0.77,3者联合的曲线下面积为0.85,3者联合的曲线下面积最大。Logistic风险回归模型显示雌二醇、孕酮、癌胚抗原水平是影响乳腺癌患者淋巴结转移的独立危险因素(均P<0.05)。结论性激素雌二醇、孕酮联合癌胚抗原对乳腺癌患者淋巴结转移有较高诊断价值,可独立预测乳腺癌患者是否发生淋巴结转移。 Objective To analyze the diagnostic value of sex hormone combined with carcinoembryonic antigen on lymph node metastasis in breast cancer patients.Methods 52 cases of breast cancer patients who underwent surgical resection were collected and divided into non-metastasis group and metastases group after axillary lymph node ultrasonography.The blood samples was collected from patients and the levels of serum estradiol,testosterone,progesterone and carcinoembryonic antigen were detected;The diagnostic value of the above indexes in patients with lymph node metastasis was analyzed;Logistic risk regression model was used to analyze the independent risk factors for lymph node metastasis after surgical resection.Results There were significant differences between the non-metastatic group and the metastatic group in the largest tumor diameter and menopause(all P<0.05),but there were no significant differences among other general data(all P>0.05).The serum estradiol level in the non-metastatic group was(153.97±35.55)pg/ml,the progesterone level was(0.33±0.05)ng/ml,and the carcinoembryonic antigen level was(11.44±3.77)ng/ml,while the estradiol level in the metastatic group was(207.19±52.11)pg/ml(t=4.13,P<0.001),progesterone level(0.38±0.04)ng/ml(t=4.01,P<0.001),carcinoembryonic antigen level(15.41±3.46)ng/ml(t=3.94,P<0.001).The above three indicators were significantly increased in patients in the transfer group.The area under the curve of estradiol was 0.83,the area under the curve of progesterone was 0.80,the area under the curve of carcinoembryonic antigen was 0.77,the area under the curve of the combination of the three was 0.85,and the area under the curve of the combination of the three was the largest.Logistic risk regression model showed that estradiol,progesterone,and carcinoembryonic antigen levels were independent risk factors affecting lymph node metastasis in breast cancer patients(all P<0.05).Conclusion The sex hormone estradiol,progesterone combined with carcinoembryonic antigen has a high diagnostic valu
作者 郭秀芳 刘志鹏 李超 胡耀峰 朱爱萍 Guo Xiufang;Liu Zhipeng;Li Chao;Hu Yaofeng;Zhu Aiping(Clinical Laboratory,the Second Hospital of Shanxi Medical University,Taiyuan 030001,China;Clinical Laboratory,Shanxi Provincial Hospital of Traditional Chinese Medicine,Taiyuan 030012,China;Department of Breast surgery,the Second Hospital of Shanxi Medical University,Taiyuan 030001,China)
出处 《中华内分泌外科杂志》 CAS 2023年第2期162-165,共4页 Chinese Journal of Endocrine Surgery
基金 山西省重点研发计划项目(201803D31118)。
关键词 性激素 癌胚抗原 乳腺癌 淋巴结转移 Sex hormone Carcinoembryonic antigen Breast cancer Lymph node metastasis
  • 相关文献

参考文献8

二级参考文献75

  • 1胡礼仪,陈士军,李志沭,周漫波,李毅.乳腺癌患者联合检测CA15—3、CA125、CEA、SF的临床价值[J].中国医师进修杂志(外科版),2007,30(12):28-30. 被引量:15
  • 2GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact sheets_cancer.aspx. 被引量:1
  • 3Gerber ]3, Mfiller H, Reimer T, et al. Nutrition and lifestyle factors on the risk of developing breast cancer[J]. Breast Cancer Res Treat, 2003, 79(2): 265-276. 被引量:1
  • 4Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same disease in Asian and Western countries ? [J]. World World J Surg, 2010, 34(10): 2308-2324. 被引量:1
  • 5Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis[J]. Lancet, 2011,378(9801): 1461-1484. 被引量:1
  • 6Rusner C, Bandemer-Greulich U, Engel J, et al. Population-based hormone receptor-specific incidence trends of breast cancer in Germany[J]. Maturitas, 2012, 73(2): 1S2-157. 被引量:1
  • 7Shen YC, Chang CJ, Hsu C, et al. Significant difference in the trends of female breast cancer incidence between Taiwan Residents and Caucasian Americans: implications from age-period-cohort analysis[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(8): 1986-1990. 被引量:1
  • 8Shin HR, Joubert C, Boniol M, et al. Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women[J]. Cancer Causes Control, 2010, 21(11): 1777-1785. 被引量:1
  • 9Glass AG, LaceyJVJr, CarreonJD, et al. Breast cancer incidence, 1980- 2006: combined roles of menopausal hormone therapy, screeningmammography, and estrogen receptor status[J]. J Natl Cancer Inst, 2007, 99(15): 1152-1161. 被引量:1
  • 10Kelsey JL. Breast cancer epidemiology: summary and future directions [ J ]. Epidemiol Rev, 1993, 1S ( 1 ): 256-263. 被引量:1

共引文献59

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部